Atorvastatin Calcium Tablets — Class II drug recall D-1086-2014
Terminated recall by Ranbaxy Inc., reported 2014-03-05, distributed nationwide. Presence of Foreign Tablets: A product complaint was received by a pharmacist who discovered an Atorvastatin 2
| Recall number | D-1086-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Ranbaxy Inc., Princeton, NJ, United States |
| Recall initiated | 2014-01-16 |
| Classified | 2014-02-21 |
| Reported by FDA | 2014-03-05 |
| Terminated | 2015-01-14 |
| Distributed | Nationwide (US) |
| Quantity | 64,626 bottles |
| NDC | 63304-0827, 63304-0827-05, 63304-0827-90, 63304-0828, 63304-0828-05, 63304-0828-90, 63304-0829, 63304-0829-05, 63304-0829-90, 63304-0830, 63304-0830-05, 63304-0830-90 |
Product
Atorvastatin Calcium Tablets, 10 mg, 90-count tablets per bottle, Rx only, Manufactured for: Ranbaxy Pharmaceuticals Inc., Jacksonville, FL 32257 USA; by: Ranbaxy Laboratories Ltd., New Delhi -110 019, India; NDC 63304-827-90
Reason for recall
Presence of Foreign Tablets: A product complaint was received by a pharmacist who discovered an Atorvastatin 20 mg tablet inside a sealed bottle of 90-count Atorvastatin 10 mg.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1086-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.